Skip to main content
SpringerLink
Log in

Retinal Astrocytic Tumors

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 444 Accesses

Abstract

Retinal astrocytic tumors are benign glial tumors represented by two clinical types: retinal astrocytic hamartoma and “acquired” retinal astrocytoma. Retinal astrocytic hamartomas are frequently associated with tuberous sclerosis complex (TSC). “Acquired” retinal astrocytomas develop in somewhat older individuals who have no clinical manifestations of TSC or other systemic syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Destro M, D’Amico DJ, Gragoudas ES, et al. Retinal manifestations of neurofibromatosis. Diagnosis and management. Arch Ophthalmol. 1991;109:662–6.

    Article  CAS  Google Scholar 

  2. De Bustros S, Miller NR, Finkelstein D. Bilateral astrocytic hamartomas of the optic nerve heads in retinitis Pigmentosa. Retina. 1983;3:21–3.

    Article  Google Scholar 

  3. Gunduz K, Eagle RC Jr, Shields CL, et al. Invasive giant cell astrocytoma of the retina in a patient with tuberous sclerosis. Ophthalmology. 1999;106:639–42.

    Article  CAS  Google Scholar 

  4. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277:805–8.

    Article  Google Scholar 

  5. Consortium ECTS. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305–15.

    Article  Google Scholar 

  6. Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A. 2002;99:13571–6.

    Article  CAS  Google Scholar 

  7. Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet. 1999;64:1305–15.

    Article  CAS  Google Scholar 

  8. Jones AC, Daniells CE, Snell RG, et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet. 1997;6:2155–61.

    Article  CAS  Google Scholar 

  9. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68:64–80.

    Article  CAS  Google Scholar 

  10. Aronow ME, Nakagawa JA, Gupta A, et al. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings. Ophthalmology. 2012;119:1917–23.

    Article  Google Scholar 

  11. Jakobiec FA, Brodie SE, Haik B, et al. Giant cell astrocytoma of the retina. A tumor of possible Mueller cell origin. Ophthalmology. 1983;90:1565–76.

    Article  CAS  Google Scholar 

  12. Giles J, Singh AD, Rundle PA, et al. Retinal astrocytic hamartoma with exudation. Eye. 2005;19:724–5.

    Article  CAS  Google Scholar 

  13. Mennel S, Meyer CH, Peter S, et al. Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand. 2007;85:127–32.

    Article  Google Scholar 

  14. de Juan E Jr, Green WR, Gupta PK, et al. Vitreous seeding by retinal astrocytic hamartoma in a patient with tuberous sclerosis. Retina. 1984;4:100–2.

    Article  Google Scholar 

  15. Kroll AJ, Ricker DP, Robb RM, et al. Vitreous hemorrhage complicating retinal astrocytic hamartoma. Surv Ophthalmol. 1981;26:31–8.

    Article  CAS  Google Scholar 

  16. Nyboer JH, Robertson DM, Gomez MR. Retinal lesions in tuberous sclerosis. Arch Ophthalmol. 1976;94:1277–80.

    Article  CAS  Google Scholar 

  17. Robertson DM. Ophthalmic manifestations of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:17–25.

    Article  CAS  Google Scholar 

  18. Zimmer-Galler IE, Robertson DM. Long-term observation of retinal lesions in tuberous sclerosis. Am J Ophthalmol. 1995;119:318–24.

    Article  CAS  Google Scholar 

  19. Rowley SA, O'Callaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol. 2001;85:420–3.

    Article  CAS  Google Scholar 

  20. Mennel S, Meyer CH, Eggarter F, et al. Autofluorescence and angiographic findings of retinal astrocytic hamartomas in tuberous sclerosis. Ophthalmologica. J Int D’ophtalmol Int J Ophthalmol Zeitschrift fur Augenheilkunde. 2005;219:350–6.

    Article  Google Scholar 

  21. Shields CL, Say EAT, Fuller T, et al. Retinal astrocytic hamartoma arises in nerve Fiber layer and shows “Moth-Eaten” optically empty spaces on optical coherence tomography. Ophthalmology. 2016;123:1809–16.

    Article  Google Scholar 

  22. Pichi F, Massaro D, Serafino M, et al. RETINAL ASTROCYTIC HAMARTOMA: optical coherence tomography classification and correlation with tuberous sclerosis complex. Retina. 2016;36:1199–208.

    Article  Google Scholar 

  23. Shields CL, Benevides R, Materin MA, et al. Optical coherence tomography of retinal astrocytic hamartoma in 15 cases. Ophthalmology. 2006;113:1553–7.

    Article  Google Scholar 

  24. Xu L, Burke TR, Greenberg JP, et al. Infrared imaging and optical coherence tomography reveal early-stage astrocytic hamartomas not detectable by fundoscopy. Am J Ophthalmol. 2012;153:883–9.e2.

    Article  Google Scholar 

  25. Howard GM, Ellsworth RM. Differential diagnosis of retinoblastoma. A statistical survey of 500 children. I. Relative frequency of the lesions which simulate retinoblastoma. Am J Ophthalmol. 1965;60:610–8.

    Article  CAS  Google Scholar 

  26. Reese AB. Relation of drusen of the optic nerve to tuberous sclerosis. Arch Ophthalmol. 1940;24:187–205.

    Article  Google Scholar 

  27. Panzo GJ, Meyers SM, Gutman FA, et al. Spontaneous regression of parafoveal exudates and serous retinal detachment in a patient with tuberous sclerosis and retinal astrocytomas. Retina. 1984;4:242–5.

    Article  CAS  Google Scholar 

  28. Bloom SM, Mahl CF. Photocoagulation for serous detachment of the macula secondary to retinal astrocytoma. Retina. 1991;11:416–22.

    Article  CAS  Google Scholar 

  29. Vrabec TR, Augsburger JJ. Exudative retinal detachment due to small noncalcified retinal astrocytic hamartoma. Am J Ophthalmol. 2003;136:952–4.

    Article  Google Scholar 

  30. Mennel S, Hausmann N, Meyer CH, et al. Photodynamic therapy for exudative hamartoma in tuberous sclerosis. Arch Ophthalmol. 2006;124:597–9.

    Article  Google Scholar 

  31. Drummond SR, Kemp EG. Retinal astrocytoma managed by brachytherapy. Ophthalmology. 2009;116:597–e1.

    Article  Google Scholar 

  32. Eskelin S, Tommila P, Palosaari T, et al. Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas. Acta Ophthalmol. 2008;86:794–9.

    Article  Google Scholar 

  33. Vilaplana D, Castilla M, Poposki V, et al. Acquired retinal astrocytoma managed with endoresection. Retina. 2006;26:1081–2.

    Article  Google Scholar 

  34. Nakayama M, Keino H, Hirakata A, et al. Exudative retinal astrocytic hamartoma diagnosed and treated with pars plana vitrectomy and intravitreal bevacizumab. Eye. 2012;26:1272–3.

    Article  CAS  Google Scholar 

  35. Shields CL, Materin MA, Marr BP, et al. Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy. Arch Ophthalmol. 2008;126:273–4.

    Article  Google Scholar 

  36. Tomida M, Mitamura Y, Katome T, et al. Aggressive retinal astrocytoma associated with tuberous sclerosis. Clin Ophthalmol. 2012;6:715–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Singh AD. Neoplastic diseases of the retina. In: Agarwal A, editor. Gass’ atlas of macular diseases. 5th ed. Edinburgh: Elsevier; 2011. p. 1116.

    Google Scholar 

  38. Jost BF, Olk RJ. Atypical retinitis proliferans, retinal telangiectasis, and vitreous hemorrhage in a patient with tuberous sclerosis. Retina. 1986;6:53–6.

    Article  CAS  Google Scholar 

  39. Atkinson A, Sanders MD, Wong V. Vitreous haemorrhage in tuberous sclerosis. Report of two cases. Br J Ophthalmol. 1973;57:773–9.

    Article  CAS  Google Scholar 

  40. Nallasamy N, Seider MI, Gururangan S, et al. Everolimus to treat aggressive retinal astrocytic hamartoma in tuberous sclerosis complex. J AAPOS. 2017;21:328–31.

    Article  Google Scholar 

  41. Zhang ZQ, Shen C, Long Q, et al. Sirolimus for retinal astrocytic hamartoma associated with tuberous sclerosis complex. Ophthalmology. 2015;122:1947–9.

    Article  Google Scholar 

  42. Shields JA, Eagle RC Jr, Shields CL, et al. Aggressive retinal astrocytomas in 4 patients with tuberous sclerosis complex. Arch Ophthalmol. 2005;123:856–63.

    Article  Google Scholar 

  43. Arnold AC, Hepler RS, Yee RW, et al. Solitary retinal astrocytoma. Surv Ophthalmol. 1985;30:173–81.

    Article  CAS  Google Scholar 

  44. Lagos JC, Gomez MR. Tuberous sclerosis: reappraisal of a clinical entity. Mayo Clin Proc Mayo Clin. 1967;42:26–49.

    CAS  PubMed  Google Scholar 

  45. Kiribuchi K, Uchida Y, Fukuyama Y, et al. High incidence of fundus hamartomas and clinical significance of a fundus score in tuberous sclerosis. Brain Dev. 1986;8:509–17.

    Article  CAS  Google Scholar 

  46. Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med: Off J Am Coll Med Genet. 2007;9:88–100.

    Article  CAS  Google Scholar 

  47. Shields CL, Reichstein DA, Bianciotto C, et al. Retinal pigment epithelial depigmented lesions associated with tuberous sclerosis complex. Arch Ophthalmol. 2012;130:387–90.

    Article  Google Scholar 

  48. Cohen VM, Shields CL, Furuta M, et al. Vitreous seeding from retinal astrocytoma in three cases. Retina. 2008;28:884–8.

    Article  Google Scholar 

  49. Shields CL, Shields JA, Eagle RC Jr, et al. Progressive enlargement of acquired retinal astrocytoma in 2 cases. Ophthalmology. 2004;111:363–8.

    Article  Google Scholar 

  50. Moschos MM, Chamot L, Schalenbourg A, et al. Spontaneous regression of an isolated retinal astrocytic hamartoma. Retina. 2005;25:81–2.

    Article  Google Scholar 

  51. Kiratli H, Bilgic S. Spontaneous regression of retinal astrocytic hamartoma in a patient with tuberous sclerosis. Am J Ophthalmol. 2002;133:715–6.

    Article  Google Scholar 

  52. Reeser FH, Aaberg TM, Van Horn DL. Astrocytic hamartoma of the retina not associated with tuberous sclerosis. Am J Ophthalmol. 1978;86:688–98.

    Article  CAS  Google Scholar 

  53. Ramsay RC, Kinyoun JL, Hill CW, et al. Retinal astrocytoma. Am J Ophthalmol. 1979;88:32–6.

    Article  CAS  Google Scholar 

  54. Ulbright TM, Fulling KH, Helveston EM. Astrocytic tumors of the retina. Differentiation of sporadic tumors from phakomatosis-associated tumors. Arch Pathol Lab Med. 1984;108:160–3.

    CAS  PubMed  Google Scholar 

  55. Singh AD, Soto H, Bellerive C, et al. Reactive retinal astrocytic tumor (focal nodular gliosis): report of the clinical Spectrum of 3 cases. Ocul Oncol Pathol. 2017;3:235–9.

    Article  Google Scholar 

  56. Poole Perry LJ, Jakobiec FA, Zakka FR, et al. Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol. 2013;155:593–608.e1. 608.e1.

    Article  Google Scholar 

  57. Jakobiec FA, Thanos A, Stagner AM, et al. So-called massive retinal gliosis: a critical review and reappraisal. Surv Ophthalmol. 2016;61:339–56.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Severance Hospital, Yonsei University, College of Medicine, Seoul, South Korea

    Christopher Seungkyu Lee & Sungchul Lee

  2. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

Authors
  1. Christopher Seungkyu Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sungchul Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arun D. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sungchul Lee .

Editor information

Editors and Affiliations

  1. Cleveland Clinic Foundation, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

    Arun D. Singh

  2. University of Oxford, Oxford, UK

    Bertil E. Damato

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lee, C.S., Lee, S., Singh, A.D. (2019). Retinal Astrocytic Tumors. In: Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-04113-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04113-7_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04112-0

  • Online ISBN: 978-3-030-04113-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation